Group 1: A one-time ex vivo perfusion is carried out on surgical resectates. The surgery occurs independently of this trial. After the perfusion only tissue that is not required for clinical diagnosti
Sponsors
Universitätsklinikum Augsburg
Conditions
C34C78.7
Unknown Phase
Ex vivo Identification of Specific Gene Vector Capsids for Non-Small Cell Lung Cancer-targeted Gene Therapy with Adeno-associated Viral Vectors
The AAV Augsburg-Hamburg oncology interventional (AH-OI) Trial 02
RecruitingDRKS00036704
Start: 2025-09-26Target: 24Updated: 2025-10-06
Ex vivo Identification of Specific Gene Vector Capsids for Liver-Metastases-targeted Gene Therapy with Adeno-associated Viral Vectors
The AAV Augsburg-Hamburg oncology interventional (AH-OI) Trial 03
RecruitingDRKS00036729
Start: 2025-06-27Target: 24Updated: 2026-01-12